Even with Dr. Missling's sketchy relationship with dates and calendars it seems to me that there is something very big playing out. No material updates really since last December. No new trials have started when we were told as early as last June that we should expect at least 3 or 4 new trials to begin before the end of 2022. Here we are knocking on the door of Sept 2023 and still no trials started. WHY? Are they starting them without telling us? Is it material that they tell us? What about the Rett results, where are they? They could have had top line results out already. I remember a long time ago Dr. Missling told me that top line results can be released very fast within weeks if they wanted to. Our stock price is pinned to a range, 7.50 - 9.50 . Typically you see that just before an explosion. Is the Dr. waiting for a Q3 big event where they will announce a huge partnership along with a buy in of stock by the partner? At the same time announce Rett and Alz data which explains why the partnership now? Announce the guidance by the FDA for both Alz and Rett which is why we need the partnership now, to run whatever trials the FDA wants to see.. Also announce the new trial starts ( 371, rare diseasse, etc. ) and use the $500M - $1B we get up front from the partner to help off set those costs. All irrefutable data that will make AF go away for good. The stock goes to $35ish on the news and new buyers come in to take some of our shares off our retail plates. But not before the $30's. Thoughts??
